1.Application value of contrast-enhanced ultrasound combined with time-intensity curve to identify benign and malignant orbital neoplasms
Gang BAI ; Wenwei CHEN ; Bin SUN ; Liao CHEN ; Ying KANG ; Ji CHEN
Chinese Journal of Ultrasonography 2013;(1):63-66
Objective To explore the value of ultrasound-enhanced ultrasound (CEUS) in the differential diagnosis of orbital neoplasms by observing the perfusion characteristics of orbital benign and malignant neoplasms for the application of ultrasound contrast microbubbles.Methods Preoperative ultrasound imaging of 47 patients with orbital neoplasms(benign group 35 cases,malignant group 12 cases)were observed for the tumor characteristics of CEUS.The parameters of tumor imaging obtained time intensity curve (TIC) were obtained by quantitative analysis of SonoLiver analysis software,which were contrast agent arrive time (AT),rise time (RT),time to peak (TTP),mean transit time (mTT),area under the curve (AUC),maximum intensity(IMAX) and perfusion index (PI).Results Different characteristics of perfusion were shown between benign and malignant groups.Time parameters of TIC:rising slope,semidescending slope,IMAX,PI,mTT,semi-washed out time and RT were significantly different between the two groups (P < 0.05) while there was no significant difference of parameters as AT,TTP,AUC.Conclusions There is certain clinical value of the CEUS in the differential diagnosis of ocular benign and malignant neoplasms.
2.Metabolic characteristics of nonalcoholic fatty liver disease and related risk factors in non-obese population
Tian TIAN ; Wenwei HU ; Xue LI ; Ji LI ; Dan ZHANG ; Changzheng LI
Journal of Clinical Hepatology 2020;36(6):1310-1313
ObjectiveTo investigate the metabolic characteristics of nonalcoholic fatty liver disease (NAFLD) and related risk factors in non-obese population. MethodsA retrospective analysis were performed for 12 125 individuals who underwent physical examination in Physical Examination Center of PLA Rocket Force Characteristic Medical Center from July 2013 to April 2019. According to body mass index (BMI) <25 kg/m2, these individuals were divided into non-obese group with 8528 individuals and obese group with 3597 individuals; according to the results of abdominal ultrasound, the non-obese group was further divided into NAFLD group with 1025 individuals and non-NAFLD group with 7503 individuals. According to BMI <25 kg/m2, 3281 individuals with NAFLD were divided into non-obese NAFLD subgroup with 1025 individuals and obese NAFLD group with 2256 individuals. Related clinical data were collected, including sex, age, BMI, fasting blood glucose, uric acid, total cholesterol, triglyceride, high-density lipoprotein, low-density lipoprotein, and hemoglobin. Non-normally distributed continuous data were expressed as M(P25-P75), and the Mann-Whitney U test was used for comparison between groups; the chi-square test was used for comparison of categorical data between groups. A multivariate logistic regression analysis was performed to investigate risk factors. ResultsAmong the 12 125 individuals who underwent the physical examination, the detection rate of NAFLD was 27.06%, and the detection rate of non-obese NAFLD was 8.45%, accounting for 12.02% of the non-obese population. The multivariate logistic regression analysis, based on the univariate analysis, had a diagnostic accordance rate of 89%, and the results showed that the increase in age, BMI, fasting blood glucose, uric acid, triglyceride, low-density lipoprotein, and hemoglobin were independent risk factors for non-obese NAFLD (odds ratio [OR]=1.043, 1.716, 1.161, 1.004, 1.791, 2.587, and 1.011, P<0.001, <0.001, =0.001, <0.001, <0.001, <0.001, and =0.011), suggesting that non-obese NAFLD had the strongest association with low-density lipoprotein and had no association with age, uric acid, and hemoglobin. Total cholesterol and high-density lipoprotein were non-susceptible factors for non-obese NAFLD (OR=0.521 and 0.523, P=0.007 and 0.024). ConclusionNon-obese NAFLD is closely associated with metabolic disorders, and further studies are needed to explore the association between serum cholesterol and non-obese NAFLD.
3.Replication-incompetent Adenovirus Vector-mediated MDA-7/IL-24 Selectively Induces Growth Suppression and Apoptosis of Hepatoma Cell Line SMMC-7721
WANG CONGJUN ; XUE XINBO ; YI JILIN ; WU ZAIDE ; CHEN KUN ; ZHENG JIANWEI ; JI WENWEI ; YU YUAN
Journal of Huazhong University of Science and Technology (Medical Sciences) 2008;28(1):80-83
In order to investigate the effect of replication-incompetent adenovirus vector expressing MDA-7/IL-24 on tumor growth and apoptosis of human hepatocellular carcinoma (HCC) cell line SMMC-7721 and normal liver cell line L02, the recombinant replication-incompetent Ad.mda-7 virus vector was constructed and infected into the HCC cell line SMMC-7721 and normal liver cell line L02. RT-PCR was performed to examine the expression of MDA-7 mRNA. The concentrations of MDA-7/IL-4 in culture supernatants were determined by using ELISA. MTT and Hoechst staining assay were applied to observe the inhibitory and killing effects of MDA-7 on the HCC cells. By using flow cytometry, the apoptosis, cell cycle and proliferation of SMMC-7721 and L02 cells were meas- ured. The results showed recombinant replication-incompetent virus expressing MDA-7/IL-24 was constructed successfully, and RT-PCR revealed that it could mediate the high expression of the ex- ogenous gene MDA-7/IL-24 in SMMC-7721 and L02 cells. The expression of MDA-7/IL24 proteins in the culture supernatant was detectable by ELISA. Ad.mda-7 infection induced apoptosis and growth suppression in SMMC-7721 cells and an increased percentage of HCC cells in the G2/M phase of the cell cycle, but not in L02 cells. It was concluded that mda-7/IL-24 gene, mediated with replication-incompetent adenovirus vector, could selectively induce growth suppression and apoptosis in HCC cell line SMMC-7721 but without any toxic side-effect on normal liver line L02.
4.Effect of different treatment methods of polymeric porcelain surface on its adhesion to metal brackets
JI Li ; ZHU Zhinong ; LIAN Wenwei ; LI Dongfang
Journal of Prevention and Treatment for Stomatological Diseases 2017;25(12):779-783
Objective :
To analyze and discuss the effect of 4 different surface treatment methods on the bonding effect between polymerization porcelain and metal bracket s.
Methods:
45 polymer-ceramics specimens were made and 40 of them were selected and randomly divided into 5 groups according to different surface treatment methods. A group:surface without special treatment. B group: 9.6% hydrofluoric acid gel combine with bonding agent, C group: 9.6% hydrofluoric acid gel combine with silane, D group: 35% phosphoric acid gel combine with bonding agent, E group: 35% phosphoric acid gel combine with silane. All specimens were stored in water for 24 hours at 37 ℃ after bonding 10 min utes and then cycled 500 cycles (5 ℃ to 55 ℃). To measure the shear bonding strength and record the damage cases and the adhesive remnant index.
Results :
The shear strength values were: 3.24 in the control group, 7.24 MPa in the hydrofluoric acid etching treatment group. 10.78 MPa in the hydrofluoric acid gel combined with silane group. 4.17 MPa in the phosphoric acid-only group, 6.84 MPa in the phosphoric acid gel combined with silane group. The results of each group were statistically different from those of the other four groups (P < 0.001). The rate of breakage after the removal of brackets of the hydrofluoric acid gel combined with silane group is higher than the others.
Conclusion
As to the high shear bonding strength and low rate of breakage after the removal of brackets, we recommend 35% phosphoric acid etching combining with silane coupling agent in clinical.
5.The effects analysis of anti tumor necrosis factor-ɑ in adjuvant treatment of strangulated intestinal obstruction combined with ischemic intestinal necrosis
Bo LIN ; Liang CHEN ; Xiaolong WANG ; Hongtao CAO ; Tingting TANG ; Keqiang MA ; Tengfei JI ; Tiansheng CAO ; Jian WANG ; Wenwei ZHANG ; Jianrong YANG ; Zhuocai LU ; Tian YOU ; Qingqing HE
Chinese Journal of Postgraduates of Medicine 2020;43(6):500-504
Objective:To investigate the effects of of anti tumor necrosis factor-α (TNF-α) in adjuvant treatment of strangulated intestinal obstruction combined with ischemic intestinal necrosis.Methods:From February 2011 to August 2016 in Huadu District People′s Hospital Affiliated with Southern Medical University, 122 patients with strangulated intestinal obstruction combined with ischemic intestinal necrosis were selected and were equally divided into the experimental group and control group with 61 cases in each group according to the random draw envelope principle. Conventional surgical resection and anastomosis was used in control group, the postoperative anti TNF-α therapy was given for 2 weeks based on the treatment in control group.Results:All patients completed surgery and there were no serious complications during operation.The postoperative anal exhaust time and symptom remission time in experimental group were significantly lower than those in control group: (2.14 ± 0.41) d vs. (6.24 ± 1.28) d and (3.54 ± 0.77) d vs. (6.99 ± 0.91) d ( P<0.05). The incidence of postoperative 14 d complications such as anastomotic leakage, wound infection, anastomotic stenosis and pulmonary infection in the experimental group was 4.9%(3/61), and that of the control group was 18%(11/61), and the incidence of postoperative complications in the experimental group was significantly lower than that in the control group ( P<0.05). The postoperative 1d and 7 d serum TNF-α content in the experimental group was significantly lower than that in the control group ( P<0.05). The postoperative 14 d anal function in the experimental group was significantly better than that in the control group ( P<0.05). MRASP and MSP of postoperative 14 d in experimental group were all significantly higher than those in the control group: (80.24 ± 11.39) mmHg (1 mmHg=0.133 kPa) vs. (76.24 ± 12.11) mmHg, (231.98 ± 45.29) mmHg vs. (226.39 ± 41.87) mmHg ( P<0.05). Conclusions:The anti TNF-α in adjuvant treatment of strangulated intestinal obstruction combined with ischemic intestinal necrosis can promote the recovery of clinical symptoms and inhibit the release of TNF-α. It also can reduce the incidence of postoperative complications and improve gastrointestinal motility of patients.